These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population. Yang S; Kwak S; Lee JH; Kang S; Lee SP PLoS One; 2019; 14(11):e0224626. PubMed ID: 31682638 [TBL] [Abstract][Full Text] [Related]
33. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. Pirmoazen AM; Khurana A; El Kaffas A; Kamaya A Theranostics; 2020; 10(9):4277-4289. PubMed ID: 32226553 [TBL] [Abstract][Full Text] [Related]
34. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Sumida Y; Nakajima A; Itoh Y World J Gastroenterol; 2014 Jan; 20(2):475-85. PubMed ID: 24574716 [TBL] [Abstract][Full Text] [Related]
35. Fatty liver and the metabolic syndrome. Neuschwander-Tetri BA Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250 [TBL] [Abstract][Full Text] [Related]
36. MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Lee YS; Lee JE; Yi HS; Jung YK; Jun DW; Kim JH; Seo YS; Yim HJ; Kim BH; Kim JW; Lee CH; Yeon JE; Lee J; Um SH; Byun KS Hepatol Int; 2022 Apr; 16(2):316-324. PubMed ID: 35254642 [TBL] [Abstract][Full Text] [Related]
37. A Meta-Analysis of Sleep Disorders and Nonalcoholic Fatty Liver Disease: Potential Causality and Symptom Management. Yu L; Lin C; Chen X; Teng Y; Zhou S; Liang Y Gastroenterol Nurs; 2022 Sep-Oct 01; 45(5):354-363. PubMed ID: 35913418 [TBL] [Abstract][Full Text] [Related]
38. A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose. Jiang W; Jin Q; Li C; Xun Y Turk J Gastroenterol; 2023 Nov; ():. PubMed ID: 37966266 [TBL] [Abstract][Full Text] [Related]
39. Assessment of sympathovagal balance by HRV analysis in alcoholic and nonalcoholic fatty liver disease patients. Uchil DN; Moosabba MS; Kalpana B; Grrishma B J Educ Health Promot; 2023; 12():400. PubMed ID: 38333143 [TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease is associated with decreased lung function. Lee CH; Choi SH; Chung GE; Park B; Kwak MS Liver Int; 2018 Nov; 38(11):2091-2100. PubMed ID: 29660233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]